$3.52
0.26[7.98%]
At close: Apr 23
$3.52
0[0.00%]
After Hours: 4:17PM EDT
Repare Therapeutics
(NASDAQ:RPTX)Repare Therapeutics Stock (NASDAQ:RPTX), Analyst Ratings, Price Targets, Predictions
Repare Therapeutics Inc has a consensus price target of $22.4, established from looking at the 22 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 8, 2024, February 21, 2024, and February 14, 2024. With an average price target of $10 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 184.09% upside for Repare Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Piper Sandler
Stifel
Morgan Stanley
Guggenheim
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Repare Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/08/2024 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 184.09% | HC Wainwright & Co. | Robert Burns | → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 184.09% | HC Wainwright & Co. | Robert Burns | → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/14/2024 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 184.09% | HC Wainwright & Co. | Robert Burns | $25 → $10 | Maintains | Buy | Get Alert |
| 11/20/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 610.23% | HC Wainwright & Co. | Robert Burns | → $25 | Reiterates | Buy → Buy | Get Alert |
| 10/16/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 610.23% | Piper Sandler | Joseph Catanzaro | $30 → $25 | Maintains | Overweight | Get Alert |
| 09/25/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 382.95% | Stifel | Benjamin Burnett | $16 → $17 | Maintains | Buy | Get Alert |
| 08/17/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 610.23% | HC Wainwright & Co. | Robert Burns | $26 → $25 | Maintains | Buy | Get Alert |
| 06/09/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 354.55% | Stifel | Benjamin Burnett | $11 → $16 | Upgrade | Hold → Buy | Get Alert |
| 06/09/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 638.64% | HC Wainwright & Co. | Robert Burns | $25 → $26 | Maintains | Buy | Get Alert |
| 04/27/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 610.23% | HC Wainwright & Co. | Robert Burns | → $25 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 610.23% | HC Wainwright & Co. | Robert Burns | → $25 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 297.73% | Morgan Stanley | Jeffrey Hung | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 326.14% | Morgan Stanley | Jeffrey Hung | $28 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/17/2022 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 610.23% | HC Wainwright & Co. | Robert Burns | $38 → $25 | Maintains | Buy | Get Alert |
| 08/08/2022 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 695.45% | Morgan Stanley | Jeffrey Hung | $30 → $28 | Maintains | Overweight | Get Alert |
| 06/06/2022 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 979.55% | HC Wainwright & Co. | Robert Burns | $54 → $38 | Maintains | Buy | Get Alert |
| 06/02/2022 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 752.27% | Piper Sandler | Joseph Catanzaro | $25 → $30 | Maintains | Overweight | Get Alert |
| 04/12/2022 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 212.5% | Stifel | Benjamin Burnett | $45 → $11 | Downgrade | Buy → Hold | Get Alert |
| 09/23/2021 | RPTX | Buy Now | Repare Therapeutics | $3.52 | 1263.64% | Stifel | Benjamin Burnett | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Repare Therapeutics (RPTX)?
The latest price target for Repare Therapeutics (NASDAQ: RPTX) was reported by HC Wainwright & Co. on March 8, 2024. The analyst firm set a price target for $10.00 expecting RPTX to rise to within 12 months (a possible 184.09% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Repare Therapeutics (RPTX)?
The latest analyst rating for Repare Therapeutics (NASDAQ: RPTX) was provided by HC Wainwright & Co., and Repare Therapeutics reiterated their buy rating.
When was the last upgrade for Repare Therapeutics (RPTX)?
The last upgrade for Repare Therapeutics Inc happened on June 9, 2023 when Stifel raised their price target to $16. Stifel previously had a hold for Repare Therapeutics Inc.
When was the last downgrade for Repare Therapeutics (RPTX)?
The last downgrade for Repare Therapeutics Inc happened on February 3, 2023 when Morgan Stanley changed their price target from $28 to $15 for Repare Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Repare Therapeutics (RPTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Repare Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Repare Therapeutics was filed on March 8, 2024 so you should expect the next rating to be made available sometime around March 8, 2025.
Is the Analyst Rating Repare Therapeutics (RPTX) correct?
While ratings are subjective and will change, the latest Repare Therapeutics (RPTX) rating was a reiterated with a price target of $0.00 to $10.00. The current price Repare Therapeutics (RPTX) is trading at is $3.52, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.